Allergan Says JUVÉDERM VOLBELLA XC Now Available In U.S

(RTTNews) - Allergan plc (AGN) announced that the latest addition to the JUVÉDERM collection of fillers, JUVÉDERM VOLBELLA XC, is now available to physicians and patients for use in the lips for lip augmentation and for correction of perioral rhytids, commonly referred to as "lipstick lines", in adults over the age of 21.

In clinical trials, JUVÉDERM VOLBELLA XC was found to effectively increase lip fullness and soften the appearance of lines around the mouth in a majority of subjects through one year. JUVÉDERM VOLBELLA XC is the only filler proven to last through one year in both the lips and perioral rhytids with optimal treatment.

JUVÉDERM VOLBELLA XC injectable gel is for injection into the lips for lip augmentation and for correction of perioral lines in adults over the age of 21.